Terms: = Ovarian cancer AND SPECC1, FLJ36955, CYTSB, 92521, ENSG00000128487, Q5M775, NSP, HCMOGT-1
12 results:
1. Distinct Side Population Cell Subtypes Have Different Stemness Levels in Human ovarian cancer Cells.
Weng YJ; Zhang XX; Wu X; Guo LL; Wang CY
Curr Med Sci; 2021 Feb; 41(1):127-132. PubMed ID: 33582916
[TBL] [Abstract] [Full Text] [Related]
2. Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib.
Pathade AD; Kommineni N; Bulbake U; Thummar MM; Samanthula G; Khan W
AAPS PharmSciTech; 2019 Aug; 20(7):276. PubMed ID: 31388783
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of Circular RNA VPS13C-has-circ-001567 Promotes ovarian cancer Cell Proliferation and Invasion.
Bao L; Zhong J; Pang L
Cancer Biother Radiopharm; 2019 Mar; 34(2):110-118. PubMed ID: 30376358
[TBL] [Abstract] [Full Text] [Related]
4. Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
Reimer D; Boesch M; Wolf D; Marth C; Sopper S; Hatina J; Altevogt P; Parson W; Hackl H; Zeimet AG
Int J Cancer; 2018 Apr; 142(8):1640-1651. PubMed ID: 29194596
[TBL] [Abstract] [Full Text] [Related]
5. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop.
Thakur B; Ray P
J Exp Clin Cancer Res; 2017 Nov; 36(1):164. PubMed ID: 29169370
[TBL] [Abstract] [Full Text] [Related]
6. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
Wei Z; Wang Y; Yu X; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
[TBL] [Abstract] [Full Text] [Related]
7. ovarian cancer stem cells.
Zeimet AG; Reimer D; Sopper S; Boesch M; Martowicz A; Roessler J; Wiedemair AM; Rumpold H; Untergasser G; Concin N; Hofstetter G; Muller-Holzner E; Fiegl H; Marth C; Wolf D; Pesta M; Hatina J
Neoplasma; 2012; 59(6):747-55. PubMed ID: 22862176
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
[TBL] [Abstract] [Full Text] [Related]
9. [Ca(2+) is an important mediator of nanosecond steep pulse-induced apoptosis in human ovarian cancer SKOV3 cells].
Liu LJ; Zhao DY; Wang J; Yao CG; Sun CX; Tang JY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):772-6. PubMed ID: 21602122
[TBL] [Abstract] [Full Text] [Related]
10. Molecular portraits of intratumoral heterogeneity in human ovarian cancer.
Choi YP; Shim HS; Gao MQ; Kang S; Cho NH
Cancer Lett; 2011 Aug; 307(1):62-71. PubMed ID: 21481528
[TBL] [Abstract] [Full Text] [Related]
11. Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3.
Gao Q; Geng L; Kvalheim G; Gaudernack G; Suo Z
Ultrastruct Pathol; 2009; 33(4):175-81. PubMed ID: 19728235
[TBL] [Abstract] [Full Text] [Related]
12. ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.
Szotek PP; Pieretti-Vanmarcke R; Masiakos PT; Dinulescu DM; Connolly D; Foster R; Dombkowski D; Preffer F; Maclaughlin DT; Donahoe PK
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11154-9. PubMed ID: 16849428
[TBL] [Abstract] [Full Text] [Related]